Sign up
Quantellect · Congress · Trade Detail
NASDAQ: UTHRUnited Therapeutics Corporation
RepublicanHouse

Lisa C. McClain sold United Therapeutics Corporation (NASDAQ: UTHR)

Lisa C. McClain (R-MI), a U.S. Representative, has disclosed 4 trades in United Therapeutics Corporation (UTHR) since 2025, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Lisa C. McClain sold $1,001 - $15,000 of United Therapeutics Corporation (NASDAQ: UTHR) on October 31, 2025. Since that trade, UTHR is up +17.80% against the S&P 500 up +7.56%, an outperformance of +10.24%.

Across these filings, Lisa C. McClain has been a balanced trader of UTHR (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

UTHR trades
4
Disclosed Vol
$32K
Buys
2
50%
Sells
2
50%
Buy / Sell
1.00
ratio
First → Last
2025

Lisa C. McClain's UTHR trades vs the price

UTHR is up +17.80% since Lisa C. McClain sold on October 31, 2025, versus +7.56% for the S&P 500.

Performance since this trade

Price change since trade
+17.80%
S&P 500 change since trade
+7.56%
Outperformance vs S&P 500
+10.24%

All Lisa C. McClain UTHR trades

TradedTypeSizeReturnEst. profit
October 31, 2025SELL$445.43+17.80%
October 30, 2025BUY$453.53+15.69%+$1K
October 30, 2025SELL$453.53+15.69%
June 11, 2025BUY$276.47+89.79%+$7K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Lisa C. McClain & UTHR trading FAQ

Is it legal for Lisa C. McClain to trade United Therapeutics Corporation (UTHR) stock?

Yes. Members of Congress are allowed to trade individual stocks, including United Therapeutics Corporation (UTHR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Lisa C. McClain sell UTHR?

Lisa C. McClain disclosed a sale of $1,001 - $15,000 of United Therapeutics Corporation (UTHR) on October 31, 2025, according to public STOCK Act filings.

How has UTHR performed since Lisa C. McClain's trade?

Since Lisa C. McClain sold UTHR on October 31, 2025, the stock is up +17.80%, versus +7.56% for the S&P 500 over the same period, an outperformance of +10.24%.

How many times has Lisa C. McClain traded UTHR?

Lisa C. McClain has disclosed 4 UTHR trades since 2025 (2 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional UTHR trades?

Quantellect tracks every disclosed congressional trade in United Therapeutics Corporation (UTHR) on the United Therapeutics Corporation congressional trading page, which aggregates filings across all members of Congress.

Lisa C. McClain's UTHR tradesAll congressional filings for United Therapeutics CorporationLisa C. McClain's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.